237 related articles for article (PubMed ID: 32500440)
1. Fluorescein-mediated sonodynamic therapy in a rat glioma model.
Prada F; Sheybani N; Franzini A; Moore D; Cordeiro D; Sheehan J; Timbie K; Xu Z
J Neurooncol; 2020 Jul; 148(3):445-454. PubMed ID: 32500440
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model.
Suehiro S; Ohnishi T; Yamashita D; Kohno S; Inoue A; Nishikawa M; Ohue S; Tanaka J; Kunieda T
J Neurosurg; 2018 Dec; 129(6):1416-1428. PubMed ID: 29350596
[TBL] [Abstract][Full Text] [Related]
3. MR-guided Focused Ultrasound Facilitates Sonodynamic Therapy with 5-Aminolevulinic Acid in a Rat Glioma Model.
Wu SK; Santos MA; Marcus SL; Hynynen K
Sci Rep; 2019 Jul; 9(1):10465. PubMed ID: 31320671
[TBL] [Abstract][Full Text] [Related]
4. Intracranial Sonodynamic Therapy With 5-Aminolevulinic Acid and Sodium Fluorescein: Safety Study in a Porcine Model.
Raspagliesi L; D'Ammando A; Gionso M; Sheybani ND; Lopes MB; Moore D; Allen S; Gatesman J; Porto E; Timbie K; Franzini A; Di Meco F; Sheehan J; Xu Z; Prada F
Front Oncol; 2021; 11():679989. PubMed ID: 34235081
[TBL] [Abstract][Full Text] [Related]
5. In vitro study of haematoporphyrin monomethyl ether-mediated sonodynamic effects on C6 glioma cells.
Li JH; Song DY; Xu YG; Huang Z; Yue W
Neurol Sci; 2008 Sep; 29(4):229-35. PubMed ID: 18810596
[TBL] [Abstract][Full Text] [Related]
6. Sonodynamic therapy for gliomas.
Bunevicius A; Pikis S; Padilla F; Prada F; Sheehan J
J Neurooncol; 2022 Jan; 156(1):1-10. PubMed ID: 34251601
[TBL] [Abstract][Full Text] [Related]
7. Sonodynamic Therapy for Malignant Glioma Using 220-kHz Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound and 5-Aminolevulinic acid.
Yoshida M; Kobayashi H; Terasaka S; Endo S; Yamaguchi S; Motegi H; Itay R; Suzuki S; Brokman O; Shapira Y; Moriyama K; Kawase Y; Akahane T; Kato Y; Kamada H; Houkin K
Ultrasound Med Biol; 2019 Feb; 45(2):526-538. PubMed ID: 30522817
[TBL] [Abstract][Full Text] [Related]
8. The Immunomodulatory Effects of Fluorescein-Mediated Sonodynamic Treatment Lead to Systemic and Intratumoral Depletion of Myeloid-Derived Suppressor Cells in a Preclinical Malignant Glioma Model.
Pellegatta S; Corradino N; Zingarelli M; Porto E; Gionso M; Berlendis A; Durando G; Maffezzini M; Musio S; Aquino D; DiMeco F; Prada F
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398183
[TBL] [Abstract][Full Text] [Related]
9. Sonodynamic therapy consisting of focused ultrasound and a photosensitizer causes a selective antitumor effect in a rat intracranial glioma model.
Nonaka M; Yamamoto M; Yoshino S; Umemura S; Sasaki K; Fukushima T
Anticancer Res; 2009 Mar; 29(3):943-50. PubMed ID: 19414331
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the tumoricidal effects of sonodynamic therapy in malignant glioblastoma brain tumors.
Sheehan K; Sheehan D; Sulaiman M; Padilla F; Moore D; Sheehan J; Xu Z
J Neurooncol; 2020 May; 148(1):9-16. PubMed ID: 32361864
[TBL] [Abstract][Full Text] [Related]
11. Sinoporphyrin sodium is a promising sensitizer for photodynamic and sonodynamic therapy in glioma.
An YW; Liu HQ; Zhou ZQ; Wang JC; Jiang GY; Li ZW; Wang F; Jin HT
Oncol Rep; 2020 Oct; 44(4):1596-1604. PubMed ID: 32945475
[TBL] [Abstract][Full Text] [Related]
12. Manipulation of Mitophagy by "All-in-One" nanosensitizer augments sonodynamic glioma therapy.
Qu F; Wang P; Zhang K; Shi Y; Li Y; Li C; Lu J; Liu Q; Wang X
Autophagy; 2020 Aug; 16(8):1413-1435. PubMed ID: 31674265
[TBL] [Abstract][Full Text] [Related]
13. Evaluation the Effect of Sonodynamic Therapy with 5-Aminolevulinic Acid and Sodium Fluorescein by Preclinical Animal Study.
Huang CY; Li JC; Chen KT; Lin YJ; Feng LY; Liu HL; Wei KC
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254744
[TBL] [Abstract][Full Text] [Related]
14. Porphyrin derivatives-mediated sonodynamic therapy for malignant gliomas in vitro.
Endo S; Kudo N; Yamaguchi S; Sumiyoshi K; Motegi H; Kobayashi H; Terasaka S; Houkin K
Ultrasound Med Biol; 2015 Sep; 41(9):2458-65. PubMed ID: 26071619
[TBL] [Abstract][Full Text] [Related]
15. Study of the mechanism of sonodynamic therapy in a rat glioma model.
Song D; Yue W; Li Z; Li J; Zhao J; Zhang N
Onco Targets Ther; 2014; 7():1801-10. PubMed ID: 25336971
[TBL] [Abstract][Full Text] [Related]
16. Sonodynamic Therapy for Gliomas. Perspectives and Prospects of Selective Sonosensitization of Glioma Cells.
Bilmin K; Kujawska T; Grieb P
Cells; 2019 Nov; 8(11):. PubMed ID: 31766152
[TBL] [Abstract][Full Text] [Related]
17. Effects of combined sonodynamic and photodynamic therapies with photolon on a glioma C6 tumor model.
Tserkovsky DA; Alexandrova EN; Chalau VN; Istomin YP
Exp Oncol; 2012 Dec; 34(4):332-5. PubMed ID: 23302991
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermotherapy enhances antitumor effect of 5-aminolevulinic acid-mediated sonodynamic therapy with activation of caspase-dependent apoptotic pathway in human glioma.
Ju D; Yamaguchi F; Zhan G; Higuchi T; Asakura T; Morita A; Orimo H; Hu S
Tumour Biol; 2016 Aug; 37(8):10415-26. PubMed ID: 26846106
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic effect of sonodynamic therapy mediated by hematoporphyrin monomethyl ether on C6 glioma cells in vitro.
Dai S; Hu S; Wu C
Acta Neurochir (Wien); 2009 Dec; 151(12):1655-61. PubMed ID: 19597759
[TBL] [Abstract][Full Text] [Related]
20. Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat.
Ohmura T; Fukushima T; Shibaguchi H; Yoshizawa S; Inoue T; Kuroki M; Sasaki K; Umemura S
Anticancer Res; 2011 Jul; 31(7):2527-33. PubMed ID: 21873170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]